Impact of community participation on treatment outcomes and compliance of DOTS patients in Iraq

Eastern Mediterranean Health Journal

Volumn 9, Issue 4, 2003, Pages 709-717

  Niazi, A D ^a   Al Delaimi, A M ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b MINISTRY OF HEALTH   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AMBULATORY CARE; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; HOME CARE; HUMAN; IRAQ; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; SHORT COURSE THERAPY; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; COMMUNITY HEALTH CENTERS; CONSUMER PARTICIPATION; DIRECTLY OBSERVED THERAPY; FEMALE; HOME CARE SERVICES; HUMANS; IRAQ; MALE; ORGANIZATIONS; PATIENT COMPLIANCE; PROGRAM EVALUATION; SOCIAL SUPPORT; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; URBAN HEALTH SERVICES; VOLUNTARY WORKERS;

EID: 16844386195     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. March F et al. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS (London, England), 2000, 14(5):525-35.
2. Mac JT, Doordan A, Carr CA. Evaluation of the effectiveness of a directly observed therapy program with Vietnamese tuberculosis patients. Public health nursing, 1999, 16(6):426-9.
3. Weis SE et al. Treatment costs of directly observed therapy and traditional therapy for Mycobacterium tuberculosis: a comparative analysis. International journal of tuberculosis and lung disease, 1999, 3(11):976-84.
4. White AJ, Robinson-White CM, Luitel H. A report on home visiting practices conducted in remote districts of Nepal in an NGO-run tuberculosis control programme. International journal of tuberculosis and lung disease, 1999, 3(6):534-6.
5. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. International journal of tuberculosis and lung disease, 1998, 2(5):372-7.
6. Report on the Meeting of the National Managers of Tuberculosis Control Programmes in the Eastern Mediterranean Region, Beirut, Lebanon, 7-9 June 1999. Alexandria, WHO Regional Office for the Eastern Mediterranean, 2000:9 (WHO-EM/TUB/218/E/L).
7. Report on the third tuberculosis prevalence survey in Korea, Seoul. Seoul, Korean National Tuberculosis Association, 1975.
8. Aoki M. Comments on the results of the sixth tuberculosis prevalence survey in Taiwan area. Tokyo, Research Institute of Tuberculosis, Japan Antituberculosis Association, 1984.
9. Kamolratanakul P et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999, 93(5):552-7.
10. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bulletin of the International Union against Tuberculosis, 1990, 65:6-24.
11. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. International journal of tuberculosis and lung disease, 2000, 4(4):345-9.